ConductScience.org, home

Paper28096293

The role of MDM2 and MDM4 in breast cancer development and prevention.

Haupt S and 5 others. J Mol Cell Biol, 2017. Cited by 68 papers, by iCite.

Cite this record

ConductScience Library. The role of MDM2 and MDM4 in breast cancer development and prevention. Papers, record 28096293. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28096293

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The role of MDM2 and MDM4 in breast cancer development and prevention.
PubMed
Journal
J Mol Cell Biol
PubMed
Year
2017
PubMed
Publication types
Journal Article, Review, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
68
iCite
Relative citation ratio, by iCite
2.12
iCite
Revised in PubMed
2022-04-08
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Haupt SSue
2Vijayakumaran RReshma
3Miranda PJPanimaya Jeffreena
4Burgess AAndrew
5Lim EElgene
6Haupt YYgal

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
Nuclear ProteinsMajor topic
Proto-Oncogene Proteins c-mdm2Major topic
Animals
Female
Humans
Morphogenesis
Stress, Physiological
Tumor Suppressor Protein p53

Source PubMed

Download CSV of topics

References88

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
17477327Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53.Nature1995https://conductscience.org/library/papers/7477327PubMed
217363597A single nucleotide polymorphism in the MDM2 gene disrupts the oscillation of p53 and MDM2 levels in cells.Cancer Res2007https://conductscience.org/library/papers/17363597PubMed
39811461Delayed involution of the mammary epithelium in BALB/c-p53null mice.Oncogene1998https://conductscience.org/library/papers/9811461PubMed
424236052MDM2 promotes invasion and metastasis in invasive ductal breast carcinoma by inducing matrix metalloproteinase-9.PLoS One2013https://conductscience.org/library/papers/24236052PubMed
522349818Coordinate regulation of estrogen receptor β degradation by Mdm2 and CREB-binding protein in response to growth signals.Oncogene2013https://conductscience.org/library/papers/22349818PubMed
611306511Alternative and aberrant messenger RNA splicing of the mdm2 oncogene in invasive breast cancer.Cancer Res2001https://conductscience.org/library/papers/11306511PubMed
717996864Altered mammary gland development in the p53+/m mouse, a model of accelerated aging.Dev Biol2008https://conductscience.org/library/papers/17996864PubMed
812150820Alternative and aberrant splicing of MDM2 mRNA in human cancer.Cancer Cell2002https://conductscience.org/library/papers/12150820PubMed
924292333Subcellular localization of Mdm2 expression and prognosis of breast cancer.Int J Clin Oncol2014https://conductscience.org/library/papers/24292333PubMed
1017080308MDM2 SNP309 accelerates familial breast carcinogenesis independently of estrogen signaling.Breast Cancer Res Treat2007https://conductscience.org/library/papers/17080308PubMed
1124525025ARF tumor suppression in the nucleolus.Biochim Biophys Acta2014https://conductscience.org/library/papers/24525025PubMed
1210227293p63 is a p53 homologue required for limb and epidermal morphogenesis.Nature1999https://conductscience.org/library/papers/10227293PubMed
1317417639Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancer.Nat Genet2007https://conductscience.org/library/papers/17417639PubMed
1421454711Mutant p53 disrupts MCF-10A cell polarity in three-dimensional culture via epithelial-to-mesenchymal transitions.J Biol Chem2011https://conductscience.org/library/papers/21454711PubMed
1520679392The Mdm2-p53 relationship evolves: Mdm2 swings both ways as an oncogene and a tumor suppressor.Genes Dev2010https://conductscience.org/library/papers/20679392PubMed
1621316605The MDM2 promoter SNP285C/309G haplotype diminishes Sp1 transcription factor binding and reduces risk for breast and ovarian cancer in Caucasians.Cancer Cell2011https://conductscience.org/library/papers/21316605PubMed
179087426Targeted expression of MDM2 uncouples S phase from mitosis and inhibits mammary gland development independent of p53.Genes Dev1997https://conductscience.org/library/papers/9087426PubMed
1824739573Unravelling mechanisms of p53-mediated tumour suppression.Nat Rev Cancer2014https://conductscience.org/library/papers/24739573PubMed
197891224mdm2 gene alterations and mdm2 protein expression in breast carcinomas.J Pathol1995https://conductscience.org/library/papers/7891224PubMed
2023150756The Many Faces of MDM2 Binding Partners.Genes Cancer2012https://conductscience.org/library/papers/23150756PubMed

See all 88 referencesDownload CSV of references

Cited by54

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 68 citations.

PMIDTitleJournalYearIn PapersSource
42678985Association of MDM2 rs2279744 and rs937282 polymorphisms with breast cancer susceptibility and circulating MDM2 and p53 levels in Bangladeshi women: A case-control study.PLoS One2026https://conductscience.org/library/papers/42678985PubMed
41834461Exploring the Relationship Between MDM4 Gene Polymorphisms (rs1380576 and rs4245739) and Breast Cancer Susceptibility in Bangladesh: A Case-Control Study.J Clin Lab Anal2026https://conductscience.org/library/papers/41834461PubMed
40949156Emerging opportunities to treat drug-resistant breast cancer: Discovery of novel small-molecule inhibitors against different targets.Front Pharmacol2025https://conductscience.org/library/papers/40949156PubMed
40932605Molecular signatures of breast cancer in the Iranian population: a review of cell growth and cell cycle regulators.J Cancer Res Clin Oncol2025https://conductscience.org/library/papers/40932605PubMed
40308267Computational identification of potential natural terpenoid inhibitors of MDM2 for breast cancer therapy: molecular docking, molecular dynamics simulation, and ADMET analysis.Front Chem2025https://conductscience.org/library/papers/40308267PubMed
40251552CCT8 drives colorectal cancer progression via the RPL4-MDM2-p53 axis and immune modulation.BMC Med Genomics2025https://conductscience.org/library/papers/40251552PubMed
40191734Targeting MDM2-p53 interaction for breast cancer therapy.Oncol Res2025https://conductscience.org/library/papers/40191734PubMed
39940844Pharmacological Inhibition of MDM2 Induces Apoptosis in p53-Mutated Triple-Negative Breast Cancer.Int J Mol Sci2025https://conductscience.org/library/papers/39940844PubMed
39567687Normal breast tissues harbour rare populations of aneuploid epithelial cells.Nature2024https://conductscience.org/library/papers/39567687PubMed
39479021Roles of lncRNAs related to the p53 network in breast cancer progression.Front Oncol2024https://conductscience.org/library/papers/39479021PubMed
39329452SNRPB2 promotes triple-negative breast cancer progression by controlling alternative splicing of MDM4 pre-mRNA.Cancer Sci2024https://conductscience.org/library/papers/39329452PubMed
39234815FGF12 Positively Regulates Keratinocyte Proliferation by Stabilizing MDM2 and Inhibiting p53 Activity in Psoriasis.Adv Sci (Weinh)2024https://conductscience.org/library/papers/39234815PubMed
39000582HER4 Affects Sensitivity to Tamoxifen and Abemaciclib in Luminal Breast Cancer Cells and Restricts Tumor Growth in MCF-7-Based Humanized Tumor Mice.Int J Mol Sci2024https://conductscience.org/library/papers/39000582PubMed
38354236Mutant p53 protects triple-negative breast adenocarcinomas from ferroptosis in vivo.Sci Adv2024https://conductscience.org/library/papers/38354236PubMed
37804415Death-associated protein kinase 1 phosphorylates MDM2 and inhibits its protein stability and function.Arch Pharm Res2023https://conductscience.org/library/papers/37804415PubMed
37374977Effect of Borrelia burgdorferi on the Expression of miRNAs in Breast Cancer and Normal Mammary Epithelial Cells.Microorganisms2023https://conductscience.org/library/papers/37374977PubMed
37314603MDM2- an indispensable player in tumorigenesis.Mol Biol Rep2023https://conductscience.org/library/papers/37314603PubMed
37264344Effect of Smilax spp. and Phellinus linteus combination on cytotoxicity and cell proliferation of breast cancer cells.BMC Complement Med Ther2023https://conductscience.org/library/papers/37264344PubMed
37217945S100A6 inhibits MDM2 to suppress breast cancer growth and enhance sensitivity to chemotherapy.Breast Cancer Res2023https://conductscience.org/library/papers/37217945PubMed
36831624Potential Impact of PI3K-AKT Signaling Pathway Genes, KLF-14, MDM4, miRNAs 27a, miRNA-196a Genetic Alterations in the Predisposition and Progression of Breast Cancer Patients.Cancers (Basel)2023https://conductscience.org/library/papers/36831624PubMed

See all 54 cited byDownload CSV of cited by

Genes28

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
CDH1999PubTator's text mininghttps://conductscience.org/library/genes/999NCBI Gene
CDKN2A1029PubTator's text mininghttps://conductscience.org/library/genes/1029NCBI Gene
E2F11869PubTator's text mininghttps://conductscience.org/library/genes/1869NCBI Gene
EIF4E1977PubTator's text mininghttps://conductscience.org/library/genes/1977NCBI Gene
ERBB22064PubTator's text mininghttps://conductscience.org/library/genes/2064NCBI Gene
EREG2069PubTator's text mininghttps://conductscience.org/library/genes/2069NCBI Gene
ESR12099PubTator's text mininghttps://conductscience.org/library/genes/2099NCBI Gene
ESR22100PubTator's text mininghttps://conductscience.org/library/genes/2100NCBI Gene
GPT2875PubTator's text mininghttps://conductscience.org/library/genes/2875NCBI Gene
GPT284706PubTator's text mininghttps://conductscience.org/library/genes/84706NCBI Gene
LAMTOR510542PubTator's text mininghttps://conductscience.org/library/genes/10542NCBI Gene
MDM24193PubTator's text mininghttps://conductscience.org/library/genes/4193NCBI Gene
MDM44194PubTator's text mininghttps://conductscience.org/library/genes/4194NCBI Gene
NFATC24773PubTator's text mininghttps://conductscience.org/library/genes/4773NCBI Gene
PBXIP157326PubTator's text mininghttps://conductscience.org/library/genes/57326NCBI Gene
PGR5241PubTator's text mininghttps://conductscience.org/library/genes/5241NCBI Gene
RMDN355177PubTator's text mininghttps://conductscience.org/library/genes/55177NCBI Gene

See all 28 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28096293

GET https://conductscience.org/api/papers/v1/28096293/references?page=2